Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASPC-1 |
Human pancreas carcinoma cell line | ATCC CRL-1682 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
beta-TC6 |
Mouse pancreatic tumor (insulinoma) derived ß cell line | ATCC CRL-11506 | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Tsuruta et al., Hormone and Metabolic Research 2017, DOI: 10.1055/s-0043-121467 | ||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Youn et al., Scientific Reportss, 2018, 8: 12323, DOI:10.1038/s41598-018-30513-7 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Youn et al., Scientific Reports, 2018, 8:12323, DOI:10.1038/s41598-018-30513-7 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Alcantara, PhD Thesis, 2012, University of Sussex | Link | |
C3H/10T1/2 |
Mouse embryonic mesenchymal cell line | ATCC CCL-226 | Mouse | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | T. Wang et al., Phytotherapy Research., 2019, 33: 1074–1083, DOI: 10.1002/ptr.6301 | Link | |
C3H/10T1/2 |
Mouse embryonic mesenchymal cell line | ATCC CCL-226 | Mouse | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. M. Musri et al., J. Biol. Chem., Sep 2010; 285: 30034 - 30041 | Link | |
C6 |
Rat glial cell line | ATCC CCL-107 | Rat | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Serrano et al., Hindawi Mediators of Inflammation, 2017, Art.- ID 1626204, doi.org/10.1155/2017/1626204 | ||
CD4+ T cells |
Human CD4+ T cells | Human | immune system | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | J.-S. Chung et al., Eur. J. Immunol., 2011,41: 1794–1799, DOI 10.1002/eji.201041233 | ||||
CMel-2 |
Human primary superficial spreading melanoma cells | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
Daoy |
Human desmoplastic cerebellar medulloblastoma cell line | ATCC HTB-186 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
EJ138 |
Human bladder carcinoma cell line | ECACC 85061108 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
FLS |
Mouse fibroblast-like synoviocytes | Mouse | unknown | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Sekine et al., Arthritis & Rheumatology, 2014, 66 (10) :2751-2761, DOI 10.1002/art.38743 | Link | ||
G1K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
G361 |
Human skin malignant melanoma cell line | ATCC CRL-1424 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Mol. Pharmacol., Oct 2014; 86: 561 - 569 | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
G500 |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | ||
GR-M |
Human cutaneous melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. Venza et al., Biochem. and Biophys. Res. Commun., 2013, 441: 743–750, doi.org/10.1016/j.bbrc.2013.10.114 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. J. Lee et al., Mol. Therapy, 2017, 26(3): 845-859, doi.org/10.1016/j.ymthe.2017.12.015 | Link | ||
hCMEC/D3 |
Human brain-derived microvascular endothelial cells | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Krishnan et al.,Oncotarget, 2015, 6(26): 22480-22495 | Link | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. Priego et al., Oncotarget, 2016, 7 (29): 45060-45078 | Link |